Latest News about IXHL
Recent news which mentions IXHL
Cannabis Stock Movers For July 19, 2023
July 19, 2023
From Benzinga
Fortrea To Manage Incannex's FDA IND Opening Phase 2/3 Trial Of Its Dronabinol-Based Drug For Obstructive Sleep Apnea
July 18, 2023
From Benzinga
Incannex Receives HREC Approval For Phase 2 Clinical Trial Of CBD-Based Drug For Use In Treatment Of Rheumatoid Arthritis
July 13, 2023
Tickers
IXHL
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Incannex Approved For Bioavailability Clinical Trial For Dronabinol-Based Drug For Treatment Of Obstructive Sleep Apnea
July 06, 2023
Tickers
IXHL
From Benzinga
From Benzinga
Psyched: Millions From Institutional Investor And Fed Funding For Research, M&As, Women Veterans And More
June 06, 2023
From Benzinga
Why A National Cannabis Organization Sacked Half Its Staff, CEO Turnovers And More Exec Changes
June 05, 2023
From Benzinga
From Benzinga
Psychedelic Therapies Soon Available In Australia Via Incannex Healthcare And Subsidiary
May 16, 2023
Tickers
IXHL
From Benzinga
Psyched: Psychedelics Reimbursement, Amanita Muscaria Boom, $53M Material Breach Lawsuit & More
May 08, 2023
From Benzinga
Incannex Stock Trading Higher On Entering A Lease For First Psychedelic-Assisted Psychotherapy Clinic
May 05, 2023
Tickers
IXHL
From Benzinga
Psyched: Oregon And Colorado Regulations, MindMed CEO Discusses LSD Therapy, Mia Khalifa Enters Market & More
May 01, 2023
From Benzinga
From Benzinga
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More
March 20, 2023
From Benzinga
Psychedelic Trials Update: Treating Meth Addiction, Fibromyalgia & General Anxiety Disorder
March 15, 2023
From Benzinga
Why American Public Education Shares Are Trading Lower By Around 49%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 15, 2023
From Benzinga
From Benzinga
Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
March 07, 2023
From Benzinga
From Benzinga
Incannex Engages Catalent For Development And Manufacture Of Psilocybin Drug For Clinical Trials
March 03, 2023
From Benzinga
Incannex Starts Phase 2 Clinical Trial Of CBD-Based Drug For Use In Treatment Of Rheumatoid Arthritis
February 28, 2023
Tickers
IXHL
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 25, 2023
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 25, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.